Skip to Main Content

Paper Details

Maximizing the Efficacy of MAPK-Targeted Treatment in PTENLOF/BRAFMUT Melanoma through PI3K and IGF1R Inhibition.
Cancer Research
14
2016

Datasets

Release 1.2